Open Access Open Access  Restricted Access Subscription Access

Comparative Efficacy of Ondansetron Versus Granisetron to Prevent Perioperative Nausea and Vomiting in Patients undergoing Gynaecological Surgery under Spinal Anaesthesia


Affiliations
1 Department of Anesthesia, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India
 

Background: Posotoprative nausea and vomiting remains a persistent and distressing problem inspite of many advances on perioperative care and anti-emetic drugs. A newer antiemetic drug Granisetron has not been studied in patients undergoing gynaecological surgery under spinal anaesthesia.

Objective: A randomized double blind study was conducted to compare Ondansetron and Granisetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery under spinal anaesthesia.

Material and methods: 60 consecutive patients, age between 20-65 years, ASA grade I and II undergoing gynaeacologicla surgery under spinal anaesthesia were randomized into two goups of 30 each. One group received intravenous Ondansetron 4.0 mg and the second received intravenous Granisetron 2.0 mg 5 minutes before induction of anaesthesia. For the first 24 hours postoperatively all episodes of nausea and vomiting were recorded. A complete response to the drug was considered if there was no nausea or vomiting and no need for rescue anti-emetic. The observations were tabulated and analysed.

Results: During early postoperative period (0-3 hrs) there was statistically no significant difference in the study groups. Statistically significant difference was found in the study groups in the late postoperative period (3-24 hrs).

Conclusion: In the early postoperative period both Ondansetron and Granisetron are equally effective in preventing postoperative nausea and vomiting in patients undergoing gynaecological surgery under spinal anaesthesia. Granisetron is better than Ondansetron in the late postoperative period of upto 24 hrs.


Keywords

Gynaecological Surgery, Spinal Anesthesia, Postoperative Nausea and Vomiting, Ondansetron, Granisetron.
User
Notifications
Font Size


  • Kapur PA. The big little problem. Anaesthesia and Analgesia 1994;73:243-5.
  • Clarke RJS. Nausea and vomiting. Br J Anesth 1984;56:19-24.
  • Kenny GNC. Risk factors for post operative nausea and vomiting. Anaesthesia 1994;49:610.
  • Kovac AL, Eberhart L, Melson TI. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of Palonosetron versus placebo on preventing postoperative nausea and vomiting over a 72-hour period. Anasthesia Analgesia 2008;107:439-44.
  • Watcha MF, While PF. Nausea and vomiting: its etiology, treatment and prevention; Anaesthesiology 1992;77:162-18.
  • Mckenzie R, Tantisira B, Karambelkar DJ, Riley TJ, Abdelhady H. Comparison of ondansetron with ondansetron plus dexamethasone in the prevention of postoperative nausea and vomiting. Anesth Analg 1994;79:961-4.
  • Andrews PRR, Bhadari, Davey PT, Binghar S. Are all 5 HT3 receptor antagonists the same? Eur J Cancer 1992;28:52-6.
  • Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions drawn from cross validations between two centers. Eur J Anaesthiol 1999 Sep;91(3):693-700.
  • Fuji Y, Tanaka H, Toyooka H. Optimal antiemetic dose of Granisetron for preventing postoperative nausea and vomiting. Can J Anaesth 1994;41(9):794-7.
  • Fuji Y, Tanaka H, Toyooka H. Granisetron prevents nausea and vomiting during spinal anaesthesia for Caesarian section. Acta Anaesthesiol Scand 1998 March;42(3):312-5.
  • Bhattacharya D, Banerjee A. A comparison of Ondansetron and Granisetron for prevention of nausea and vomiting following day care laparoscopy. IJA 2003;47(4):279-82.
  • Chaudhari SA, Walande SS, Sirsat VS, Pachore PJ. A comparative study between Ondansetron and Granisetron pre operatively for prevention of postoperative nausea and vomiting in elective LSCS under spinal anaesthesia. Int J of Pharmacology and Therapeutics 2014;4(3):10-20.
  • Fuji Y, Saitosh Y, Tanaka H, Toyooka H. Comparison of Ramosetron and Granisetron for preventing postoperative nausea and vomiting after gynaecologic surgery. Anaesth Analg 1999;Aug 89(2):476-9.
  • McKenzie R, Kovac A, O Connor T. Comparison of Ondansetron versus placebo to prevent postoperative nausea and vomiting on women undergoing gynaecological surgery. Anaesthesiology 1993;78:21-8.
  • Kim SI, Kim SC, Baek YH, Ok SY, Kim SH. Comparison of Ramosetron with Ondansteron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Br J Anaesth 2009;103(4):549-53.

Abstract Views: 262

PDF Views: 135




  • Comparative Efficacy of Ondansetron Versus Granisetron to Prevent Perioperative Nausea and Vomiting in Patients undergoing Gynaecological Surgery under Spinal Anaesthesia

Abstract Views: 262  |  PDF Views: 135

Authors

Robina Makker
Department of Anesthesia, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India
Amit Bhardwaj
Department of Anesthesia, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India
Arwinder Pal Singh
Department of Anesthesia, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India
Asha Anand
Department of Anesthesia, Punjab Institute of Medical Sciences, Jalandhar, Punjab, India

Abstract


Background: Posotoprative nausea and vomiting remains a persistent and distressing problem inspite of many advances on perioperative care and anti-emetic drugs. A newer antiemetic drug Granisetron has not been studied in patients undergoing gynaecological surgery under spinal anaesthesia.

Objective: A randomized double blind study was conducted to compare Ondansetron and Granisetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery under spinal anaesthesia.

Material and methods: 60 consecutive patients, age between 20-65 years, ASA grade I and II undergoing gynaeacologicla surgery under spinal anaesthesia were randomized into two goups of 30 each. One group received intravenous Ondansetron 4.0 mg and the second received intravenous Granisetron 2.0 mg 5 minutes before induction of anaesthesia. For the first 24 hours postoperatively all episodes of nausea and vomiting were recorded. A complete response to the drug was considered if there was no nausea or vomiting and no need for rescue anti-emetic. The observations were tabulated and analysed.

Results: During early postoperative period (0-3 hrs) there was statistically no significant difference in the study groups. Statistically significant difference was found in the study groups in the late postoperative period (3-24 hrs).

Conclusion: In the early postoperative period both Ondansetron and Granisetron are equally effective in preventing postoperative nausea and vomiting in patients undergoing gynaecological surgery under spinal anaesthesia. Granisetron is better than Ondansetron in the late postoperative period of upto 24 hrs.


Keywords


Gynaecological Surgery, Spinal Anesthesia, Postoperative Nausea and Vomiting, Ondansetron, Granisetron.

References





DOI: https://doi.org/10.18311/ijmds%2F2017%2F125556